Fibromyalgia Treatment Market,, By Distribution Channel, By Geography

Description

Global Fibromyalgia Treatment Market is estimated to be valued at USD 3.18 Bn in 2025 and is expected to reach USD 4.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.50%	2032 Value Projection:	USD 4.05 Bn

Figure. Fibromyalgia Treatment Market Share (%), By Region 2025

Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, ligaments and tendons. It is often accompanied by fatigue, sleep issues, memory and mood issues. The exact cause of fibromyalgia is still unknown but is believed to be due to neurochemical imbalance in the brain. The symptoms negatively impact quality of life of those suffering from it. Currently there is no cure for fibromyalgia but the treatment aims to manage symptoms and improve day to day functioning. Some of the common treatment options include medications, lifestyle changes, alternate therapies, cognitive behavior therapy etc. The global fibromyalgia treatment market is expected to witness significant growth due to the increasing diagnosis rates and growing awareness about the condition.

Market Dynamics:

The global fibromyalgia treatment market is driven by the rising prevalence of fibromyalgia worldwide. As per estimates, fibromyalgia affects about 2-8% of the global population. Moreover, increasing approval of new drug formulations for fibromyalgia treatment is also boosting the market growth. However, high cost of treatment therapies and lack of cure hinders the market potential. Lack of awareness among physicians also poses a challenge. The market players have opportunities to develop novel drug formulations for fibromyalgia cure and offer treatment options at affordable prices. Increasing adoption of biologics also opens new growth avenues.

Key Features of the Study:

This report provides in-depth analysis of the global fibromyalgia treatment market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global fibromyalgia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global fibromyalgia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibromyalgia treatment market.

Market Segmentation

Drug Class:
- Antidepressants
- Antiepileptics
- Muscle Relaxants
- Analgesics
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Eli Lilly and Company
- Pfizer Inc.
- Novartis AG
- Allergan plc
- Sun Pharmaceutical Industries Ltd.
- Aptinyx Inc.
- Prismic Pharmaceuticals Inc.
- Innovative Med Concepts Inc.
- Intec Pharma Ltd.
- Astellas Pharma Inc.
- Johnson & Johnson
- GSK
- AstraZeneca plc
- Bristol Myers Squibb
- Viatris
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Sanofi

Product Code: CMI1691

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Patent Litigations
Reimbursement
Patent Landscape (ANDA/NDA Intelligence)
PEST Analysis
Porter's Analysis

4. Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Fibromyalgia Treatment Market, By Drug Class, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Antidepressants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Segment Trends
Antiepileptics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Segment Trends
Muscle Relaxants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Fibromyalgia Treatment Market, By Distribution Channel, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Fibromyalgia Treatment Market, By Region, 2020 - 2032, (USD BN)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD BN)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Allergan plc
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Aptinyx, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Prismic Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Innovative Med Concepts, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Intec Pharma Ltd
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Astellas Pharma Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Market Strategies
- GSK
- AstraZeneca plc
- Bristol Myers Squibb
- Viatris
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Sanofi

9. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us and Sales Contact